Gauchotte et al., Helfenstein et al. and Zheng et al. showed that expression of MCM6 was strongly correlated with histologic grade and clinical outcome in patients with meningiomas, chondrosarcoma and small HCC 23-25. This evidence concerns the gene MCM6 and hepatocellular carcinoma.